Marked Underestimation of Serum 25-hydroxyvitamin D Concentrations by The Abbot Architect Chemiluminescent Microparticle Immunoassay in Patients Receiving Vitamin D<inf>2</inf> Supplementation

dc.contributor.authorCharoenngam N.
dc.contributor.authorHolick M.F.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T16:51:02Z
dc.date.available2023-06-18T16:51:02Z
dc.date.issued2022-01-01
dc.identifier.citationEndocrine Practice Vol.28 No.1 (2022) , 122-123
dc.identifier.doi10.1016/j.eprac.2021.10.002
dc.identifier.eissn19342403
dc.identifier.issn1530891X
dc.identifier.pmid34656785
dc.identifier.scopus2-s2.0-85121574385
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/83939
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.titleMarked Underestimation of Serum 25-hydroxyvitamin D Concentrations by The Abbot Architect Chemiluminescent Microparticle Immunoassay in Patients Receiving Vitamin D<inf>2</inf> Supplementation
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121574385&origin=inward
oaire.citation.endPage123
oaire.citation.issue1
oaire.citation.startPage122
oaire.citation.titleEndocrine Practice
oaire.citation.volume28
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationBoston University School of Medicine
oairecerif.author.affiliationHarvard Medical School

Files

Collections